Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-Ablation MPA for Menorrhagia
NCT02449161Phase 3Terminated
- Start
- Aug 2015
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of medroxyprogesterone acetate in Menorrhagia. Started Aug 2015; status: terminated.
02
Drugs
medroxyprogesterone acetate
03
Conditions
Menorrhagia
Beyond the preview
Go deeper on NCT02449161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02449161.